Get started
Author

Komang Indra Parama Arta

Observed name: Komang Indra Parama  Arta
Institution: Udayana University
Observed institution: Udayana University
ORCID: 0009-0006-7124-9606
Observed ORCID: 0009-0006-7124-9606
OpenAlex ID: A5117434188
Atezolizumab versus pembrolizumab in the treatment of advanced triple-negative breast cancer: a Bayesian network meta-analysis of ITT and PD-L1 positive populations
2026 · I Gede Wikania Wira Wiguna, I Gede Krisna Arim Sadeva, et al. · BMC Cancer · 1
Clinical significance and diagnostic performance of maternal circulating soluble ST2 in preeclampsia: A systematic review and meta-analysis
2026 · Artha Maressa Theodora Simanjuntak, Wendy Wirya, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology
Efficacy and Safety of Chimeric Antigen Receptor-modified T Cell (car-t) Therapy in Lymphoma: an Updated Systematic Review and Meta-analysis
2026 · I Gede Krisna Arim Sadeva, I Gede Wikania Wira Wiguna, et al. · Meditory The Journal of Medical Laboratory
PDF
Evaluation of the Efficacy and Safety of Chimeric Antigen Receptor-Modified T (CAR-T) Cell Therapy in Leukemia: A Five-Year Updated Systematic Review and Meta-analysis
2025 · I Gede Wikania Wira Wiguna, I Gede Krisna Arim Sadeva, et al. · Journal of Health Science and Medical Research
PDF
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Biomarkers of Ovarian Cancer in Asian Populations: A Systematic Review and Meta-analysis
2025 · I Gede Wikania Wira Wiguna, I Gede Krisna Arim Sadeva, et al. · Oman Medical Journal
Works count: 5
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type